David B. Clayson

4.2k total citations
129 papers, 3.1k citations indexed

About

David B. Clayson is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, David B. Clayson has authored 129 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 30 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in David B. Clayson's work include Carcinogens and Genotoxicity Assessment (39 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). David B. Clayson is often cited by papers focused on Carcinogens and Genotoxicity Assessment (39 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). David B. Clayson collaborates with scholars based in Canada, United Kingdom and United States. David B. Clayson's co-authors include Georgiana M. Bonser, F. Iverson, E.A. Nera, E. Lok, J. W. Jull, K. Karpinski, David B. Levine, Leslie N. Pyrah, Rekha Mehta and Philippe Shubik and has published in prestigious journals such as Nature, The Lancet and American Psychologist.

In The Last Decade

David B. Clayson

124 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David B. Clayson Canada 32 1.2k 898 589 407 293 129 3.1k
Taijiro Matsushima Japan 28 1.1k 1.0× 1.2k 1.3× 438 0.7× 626 1.5× 232 0.8× 117 3.1k
Shigeaki Sato Japan 33 1.5k 1.3× 1.4k 1.5× 511 0.9× 214 0.5× 321 1.1× 112 3.1k
Hanspeter Witschi United States 35 763 0.7× 1.3k 1.4× 591 1.0× 267 0.7× 402 1.4× 134 3.8k
Marlin D. Friesen France 37 1.2k 1.0× 1.6k 1.8× 563 1.0× 260 0.6× 407 1.4× 105 4.3k
Fumio Furukawa Japan 28 652 0.6× 964 1.1× 307 0.5× 324 0.8× 275 0.9× 163 2.5k
Gordon C. Hard United States 37 1.1k 1.0× 1.3k 1.5× 456 0.8× 228 0.6× 328 1.1× 134 3.8k
Taijiro Matsushima Japan 31 1.3k 1.1× 1.5k 1.7× 410 0.7× 197 0.5× 538 1.8× 65 3.3k
Seiko Tamano Japan 32 1.4k 1.2× 1.4k 1.6× 478 0.8× 263 0.6× 540 1.8× 144 3.8k
Shozo Takayama Japan 29 1.8k 1.5× 1.5k 1.7× 590 1.0× 150 0.4× 393 1.3× 131 3.4k
David E. G. Shuker United Kingdom 31 1.2k 1.0× 1.4k 1.5× 602 1.0× 171 0.4× 242 0.8× 90 3.2k

Countries citing papers authored by David B. Clayson

Since Specialization
Citations

This map shows the geographic impact of David B. Clayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Clayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Clayson more than expected).

Fields of papers citing papers by David B. Clayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Clayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Clayson. The network helps show where David B. Clayson may publish in the future.

Co-authorship network of co-authors of David B. Clayson

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Clayson. A scholar is included among the top collaborators of David B. Clayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Clayson. David B. Clayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clayson, David B. & F. Iverson. (1996). Cancer Risk Assessment at the Crossroads: The Need to Turn to a Biological Approach. Regulatory Toxicology and Pharmacology. 24(1). 45–59. 8 indexed citations
2.
Lok, E., Fraser W. Scott, E.A. Nera, et al.. (1995). The effect of different levels of dietary α-linolenic and other fatty acids on mammary gland ductular cell proliferation in female Swiss Webster mice. Cancer Letters. 92(2). 229–234. 3 indexed citations
4.
Clayson, David B., Rekha Mehta, & F. Iverson. (1994). Oxidative DNA damage — The effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutation Research/Reviews in Genetic Toxicology. 317(1). 25–42. 101 indexed citations
5.
Clayson, David B.. (1993). Food Safety: Are Human Activities Really Worse Than Nature′s?. Regulatory Toxicology and Pharmacology. 17(2). 145–156. 3 indexed citations
6.
Clayson, David B., et al.. (1991). Classification of carcinogens: Polemics, pedantics, or progress?. Regulatory Toxicology and Pharmacology. 14(2). 147–166. 21 indexed citations
7.
Clayson, David B.. (1990). Introduction: An overview of current and anticipated methods for cancer prevention. Cancer Letters. 50(1). 3–9. 5 indexed citations
8.
Lok, E., Fraser W. Scott, R. Mongeau, et al.. (1990). Calorie restriction and cellular proliferation in various tissues of the female Swiss Webster mouse. Cancer Letters. 51(1). 67–73. 103 indexed citations
9.
Lok, E., et al.. (1989). Short-term effects of butylated hydroxytoluene on the Wistar rat liver, urinary bladder and thyroid gland. Cancer Letters. 46(1). 31–36. 24 indexed citations
10.
Clayson, David B.. (1989). Absence of effect in stochastic processes: Its influence on test validation and test use. Regulatory Toxicology and Pharmacology. 9(1). 23–33. 4 indexed citations
11.
Clayson, David B.. (1988). Needs for biological risk assessment in interspecies extrapolation.. Environmental Health Perspectives. 77. 93–97. 8 indexed citations
12.
13.
Douglas, George R., David H. Blakey, & David B. Clayson. (1988). Genotoxicity tests as predictors of carcinogens: An analysis. Mutation Research/Reviews in Genetic Toxicology. 196(1). 83–93. 20 indexed citations
14.
Lok, E., E.A. Nera, F. Iverson, et al.. (1988). Dietary restriction, cell proliferation and carcinogenesis: A preliminary study. Cancer Letters. 38(3). 249–255. 60 indexed citations
15.
Clayson, David B., et al.. (1987). Long-Term Psychological Sequelae of Surgically Versus Nonsurgically Treated Scoliosis. Spine. 12(10). 983–986. 74 indexed citations
16.
Mirvish, Sidney S., et al.. (1978). Inhibition of [3H]thymidine incorporation into DNA of rat esophageal epithelium and related tissues by carcinogenic N-nitroso compounds.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2). 458–66. 30 indexed citations
17.
Clayson, David B. & Philippe Shubik. (1976). The carcinogenic action of drugs.. Cancer Detection and Prevention. 1(1). 43–77. 4 indexed citations
18.
Clayson, David B.. (1975). Nutrition and experimental carcinogenesis: a review.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(11 Pt. 2). 3292–300. 53 indexed citations
19.
Clayson, David B., et al.. (1966). The metabolism of 1-phenylazo-2-naphthol in the rabbit. Biochemical Pharmacology. 15(9). 1247–1258. 27 indexed citations
20.
Bonser, Georgiana M., David B. Clayson, & J. W. Jull. (1958). SOME ASPECTS OF THE EXPERIMENTAL INDUCTION OF TUMOURS OF THE BLADDER. British Medical Bulletin. 14(2). 146–152. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026